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and enhanced binding activity in
psoriasis lesions, and is also associated
with increases in the apoptotic resis-
tance of keratinocytes (Ruckert et al
2000). The sample size of this study
was relatively small, no adjustments
were made for multiple comparisons
due to the exploratory nature of the
analyses, and placebo patients across
the six cohorts were combined into a
single group for all analyses. Despite
these limitations, this study demon-
strated substantial improvement in
psoriatic lesion severity suggesting
that CP-690,550 is a potent immuno-
suppressant. Further studies with
CP-690,550 in immune-mediated dis-
orders are warranted.
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Figure S1. CONSORT details. Patient flow for
each cohort throughout the study.
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TO THE EDITOR
Transmembrane collagen XVII is a
hemidesmosomal component that is
essential for the anchorage of epithelial
cells to the basement membrane
(Franzke et al., 2005). Mutations in
the collagen XVII gene, COL17A1, are
associated with junctional epidermoly-
sis bullosa. The majority of COL17A1
mutations lead to a premature termina-
tion codon and the absence of collagen
XVII in the skin, whereas missense
mutations or deletions of amino acids
are less common (Aumailley et al.,
2006; Varki et al., 2006). Analogously
to other collagens, the glycine
substitutions located in the largest
collagenous domain of collagen XVII,
Col15, interrupt the triple-helix forma-
tion and lead to partial unfolding of the
ectodomain (Va¨isa¨nen et al., 2005).
However, it is possible that glycine
substitutions also interfere with the
transport of collagen XVII within the
secretory pathway and its post-transla-
tional modifications and membrane
targeting.
Here we have analyzed the subcel-
lular localization of collagen XVII with
glycine substitutions G539E, G609D,
G612R, G627V, and G633D, and the
in-frame deletion of amino acids
779–787 (D779–787) expressed transi-
ently in COS-7 cells (McGrath et al.,
1996; Chavanas et al., 1997; Floeth
et al., 1998; Tasanen et al., 2000;
Va¨isa¨nen et al., 2005). Wild-type col-
lagen XVII was localized in the cell
plasma membrane in immunofluores-Abbreviations: ER, endoplasmic reticulum
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cence staining with the collagen XVII-
specific polyclonal NC16A antibody
(Figure 1a). Interestingly, the molecules
carrying glycine substitutions G539E,
G609D, or G627V were detectable
mostly as patchy intracellular staining;
there was less membrane-bound stain-
ing (Figure 1b and c). In immuno-
electron microscopy analysis of cells
transfected with wild-type collagen
XVII, gold labeling was detected in the
plasma membrane (Figure 1e). In cells
transfected with the constructs contain-
ing the mutations G609D and G627V,
gold particles were abundant in the
endoplasmic reticulum (ER) (Figure 1f),
but few gold particles were seen in
the plasma membrane (not shown).
However, in cells transfected with
the construct containing the mutation
G539E, gold particles were distributed
in both the ER and cell membrane
(Figure 1g and h).
In the ER, collagens undergo multi-
ple specific post-translational modifica-
tions, including hydroxylation of
certain proline and lysine residues and
glycosylation of some of the hydroxy-
lysine residues, and fold into their
native triple-helical conformation be-
fore export to the Golgi complex.
Accumulation of mutated polypeptides
in ER may expose them to overhydrox-
ylation and overglycosylation, as
shown for procollagens I (Baldwin
et al., 1989; Westerhausen et al.,
1990) and III (Tromp et al., 1989). To
investigate the post-translational mod-
ifications of mutated collagen XVII, the
transfected cells and their culture med-
ia were analyzed by immunoblotting
using 4–15% gradient gels and the
NC16A antibody. Full-length collagen
XVII molecules, both wild-type and
mutated, migrated similarly. In contrast,
the shed ectodomains containing the
G609D, G612R, G627V, or G633D
mutation migrated somewhat more
slowly than the wild type (Figure 2a).
In contrast, neither the mutant G539E
nor D779–787 exhibited abnormal mi-
gration. The retarded mobility of the
mutated polypeptides with Col15 gly-
cine substitutions suggests post-transla-
tional overmodification due to
conformational changes and disturbed
triple-helix formation in the Col15
domain, but the ER accumulation alone
due to NC16A glycine substitution
G539E does not lead to overprocessing
of mutated collagen XVII polypeptide.
N-glycosylation is required for accu-
rate cell surface integration of collagen
XVII (Franzke et al., 2006). To analyze
how collagen XVII passes through the ER
and the Golgi apparatus, we assessed
the ability of two endoglycosidases,
Endo H and peptide N-glycosidase F,
to remove N-linked sugars from muta-
ted collagen XVII molecules. Although
Wild type G539E
Del 779–787G627V
Figure 1. Immunofluorescence and immunoelectron microscopy analysis of wild-type and mutant
collagen XVII in COS-7 cells. COS-7 cells were transiently transfected with pcDNA3 vector coding for
wild-type collagen XVII, glycine substitutions G539E, G609D, G612R, G627V, and G633D, and a
deletion of amino acids 779–787 (D779–787) (for details see Supplementary Information). Culturing and
analysis of transfected COS-7 cells using immunoelectron microscopy are described in Supplementary
Information. In immunofluorescence staining, localization of wild-type and mutated collagen XVII in
transiently transfected COS-7 cells was analyzed with the polyclonal collagen XVII NC16A antibody as
described earlier (Huilaja et al., 2008), except that Alexa Fluor 488 goat anti-rabbit IgG (Molecular
Probes, Leiden, the Netherlands; dilution 1:200) was used as a secondary antibody. The close mutations
G609D and G612R, as well as G627V and G633D, were previously shown to alter the collagen XVII
structure similarly (Va¨isa¨nen et al., 2005), and thus only G609D and G627V were studied here. (a) Signal
for wild-type collagen XVII (in green) is present in plasma membrane, whereas collagen XVII with glycine
substitutions G539E (b), G609D (not shown), and G627V (c) is mostly detected as patchy intracellular
staining. The localization of D779–787 is similar to that of the wild type (d). Pictures were taken using
original magnification x40. In electron microscopy, gold immunolabeling of the wild-type collagen XVII
is localized to the plasma membrane (PM) (e). G627V-mutated collagen XVII gold immunolabeling is
seen in the endoplasmic reticulum (ER) (f), whereas G539E-mutated collagen gold immunolabeling is
detected more in the endoplasmic reticulum (g) and less in the plasma membrane (h). Gold particles
were manually calculated from 20 different cells in each group and the data were subjected to
Mann–Whitney U-test to justify the results. Bar¼200 nm.
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N-linked sugars remain sensitive to N-
glycosidase F, they become resistant to
Endo H after they are modified in the
medial Golgi. Digestion with N-glycosi-
dase F resulted in reduction of the
molecular mass of both full-length and
shed forms of wild-type and mutated
collagen XVII (Figure S1a). In contrast,
all forms were resistant to Endo H
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Figure 2. Immunoblotting and shedding of mutated collagen XVII. (a) The size of the mutated collagen XVII fragments was analyzed after precipitation from cell
extract (100ml) and cell culture media (400 ml) using 4–15% Ready Gel SDS-PAGE (Bio-Rad, Hercules, CA) and Western blotting with polyclonal NC16A
antibody (dilution 1:1,000) (Schumann et al., 2000). In cell extracts, the full-length collagen XVII molecules migrated similarly to the wild type. The glycine-
substituted G609D, G612R, G627V, and G633D ectodomains present in culture media migrated slightly more slowly than the wild type. The deletion of amino
acids 779–787 and the glycine-substituted G539E ectodomain showed no molecular-weight shift. The substitution V703M appears as a missense mutation
control and had no effect on migration. (b) Time-frame experiment of COS-7 cells transfected with the wild-type and mutated collagen XVII. Forty-eight hours
after transfection, the cells were surface biotinylated with delta-biotinoyl-e-aminocaproic acid N-hydroxysuccinimide ester according to the manufacturer’s
recommendations (Roche, Mannheim, Germany), changed to biotin-free medium, and cultured for 72 hours. After five washes with phosphate-buffered saline,
the cells were cultured in fresh medium supplemented with ascorbic acid. The cell extract and the media were collected at regular intervals for 72 hours and
processed separately as described by Scha¨cke et al. (1998). The precipitates were immunoblotted with streptavidin-coupled alkaline phosphatase (Roche) to
detect biotinylated collagen XVII (Franzke et al., 2002, 2006). (c) The scanning and quantitation analysis of the immunoblotting signals with Quantity One
software (Bio-Rad) showed that the shed ectodomain was clearly detectable after 2 hours in the media of cells transfected with the wild type and D779–787,
whereas the G539E, G609D, and G627V ectodomains were not notably recovered until after 6 hours.
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deglycosylation (Figure S1b). Taken to-
gether, these results indicate that glycine
substitution mutations or D779–787 do
not interfere with the N-glycosylation of
collagen XVII and its further procession
through the medial Golgi apparatus.
Thus, the partial intracellular retention
of glycine-substituted collagen XVII
molecules is not due to disturbed
N-glycosylation.
A post-translational process that dis-
tinguishes the transmembrane col-
lagens from other members of the
collagen superfamily is regulated
through proteolysis of the ectodomain
from the cell surface. The ectodomain
of collagen XVII is shed from the cell
surface by a disintegrin and metallo-
proteases (ADAMs) (Franzke et al.,
2002, 2004). To analyze the effect of
COL17A1 mutations on ectodomain
release, intact transfected COS-7 cells
were surface biotinylated. Similar to the
authentic ectodomain in keratinocytes,
the wild-type ectodomain was detect-
able within 2 hours in the cell culture
medium (Figure 2b). The glycine sub-
stitutions delayed shedding, as ectodo-
mains with the G539E, G609D, and
G627V mutations were not notably
detectable in the media until after 6
hours (Figure 2b and c). In contrast,
D779–787 was shed similarly to the wild
type (Figure 2b and c). Delayed shedding
might be explained by partial retention
of mutated collagen XVII polypeptides
in ER, as the signals were quite similar
to those of the wild type after 4 hours.
Alternatively, structural changes in the
NC16A domain due to mutations in the
NC16A or Col15 may affect ectodo-
main shedding (Va¨isa¨nen et al., 2005).
In the case of fibrillar collagens,
glycine substitutions lead to the pro-
duction of structurally altered polypep-
tides and usually cause a more severe
phenotype than null mutations (Mylly-
harju and Kivirikko, 2001). Collagen
XVII is able to better tolerate glycine
substitutions, which are associated with
a milder phenotype than null mutations
(Va¨isa¨nen et al., 2005; Aumailley et al.,
2006; Varki et al., 2006). Our data
suggest that glycine substitutions in the
Col15 domain interfere with the triple-
helix formation, transmembrane target-
ing, and ectodomain shedding of col-
lagen XVII, and that these disturbances
lead to skin blistering. G539E located
within the NC16A domain causes
intracellular protein accumulation and
delayed shedding similar to Col15
glycine substitutions, but does not lead
to overmodification of mutated poly-
peptide. Thus, it is obvious that there
are other, still unknown molecular
mechanisms contributing to biological
phenotypes of these mutations, given
that both G539E and D779–787 result
in the complete absence of collagen
XVII in patients’ skin, whereas the
glycine substitutions in Col15 cause
reduced collagen XVII expression
(McGrath et al., 1996; Tasanen et al.,
2000; Va¨isa¨nen et al., 2005).
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TO THE EDITOR
Non-bullous congenital ichthyosiform
erythroderma (NBCIE) and lamellar
ichthyosis (LI) are both heterogeneous
genetic disorders, and several causative
molecules, including ABCA12 and
transglutaminase-1 (TGase1), have
been identified (Huber et al., 1995;
Russell et al., 1995; Jobard et al., 2002;
Lefe´vre et al., 2003; Akiyama, 2006;
Lefe`vre et al., 2004, 2006). Patients
with NBCIE exhibit fine, whitish scales
on a background of erythematous
skin over the whole body. Conversely,
LI is clinically characterized by large,
thick, and dark scales over the entire
body without serious background
erythroderma.
ABCA12 missense mutations leading
to defects in the adenosine tripho-
sphate-binding cassette were reported
in LI cases (Lefe´vre et al., 2003), and
ABCA12 truncation mutations were
reported in patients with harlequin
ichthyosis (Akiyama et al., 2005; Kelsell
et al., 2005). Recently, we also identi-
fied ABCA12 missense mutations in a
small number of NBCIE cases (Natsuga
et al., 2007; Akiyama et al., 2008).
Since the first identification of
TGase1 gene (TGM1) mutations in LI
(Huber et al., 1995; Russell et al.,
1995), more than 50 TGM1 mutations
have been reported in LI. In addition,
TGM1 mutations were reported in a
subset of patients with NBCIE (Laiho
et al., 1997; Akiyama et al., 2001a;
Becker et al., 2003).
A number of reports concluded that
there was no clear correlation between
clinical differentiation of NBCIE and LI
and the genetic heterogeneity under-
lying these autosomal recessive conge-
nital ichthyoses (Hennies et al., 1998;
Richard, 2004). The clinical subgroups
of NBCIE and LI were not always
carefully and consistently recorded in
publications, and a number of genetic
studies were conducted including both
NBCIE and LI patients as autosomal
recessive congenital ichthyosis cases,
without detailed clinical information
for the patients. Thus, uncertainty has
often surrounded reports of NBCIE and
LI patients for whom there have been
accounts of published mutations, as
well as their references to previous
publications.
To assess the frequency of ABCA12
and TGM1 mutations in Japanese
NBCIE and LI families, we performed
mutational analyses in eight NBCIE
families and nine LI families as a cohort
of Japanese autosomal recessive con-
genital ichthyosis patients.
The eight unrelated NBCIE families
and nine independent LI families were
seen at Hokkaido University Hospital
or were seen by other clinicians within
Japan. All the patients included in the
study showed a typical phenotype of
either NBCIE or LI. Only one patient,
LI1, had an apparent history as a
collodion baby at birth. Fully informed
consent was obtained from the partici-
pants or their legal guardians. The study
had been evaluated and approved by
the Ethical Committee at Hokkaido
University Graduate School of Medi-
cine and was conducted according to
the Declaration of Helsinki Principles.
TGM1 and ABCA12 mutations have
been considered major causative fac-
tors of autosomal recessive congenital
ichthyosis in Japanese patients (Akiya-
ma et al., 2003, 2008), but several other
causative molecules are also known
(Akiyama and Shimizu, 2008). There-
fore, the entire coding regions of
ABCA12 and TGM1, including the
exon/intron boundaries, were se-
quenced using genomic DNA samples
from patients and their family members.
One hundred normal alleles from un-
related, healthy Japanese individuals
were sequenced as normal controls.
Among eight independent NBCIE
families (one patient in each family)
(Table 1), ABCA12 mutations were
detected in five independent NBCIE
families (one patient in each family),
even though direct sequence analysis
revealed no TGM1 mutation in the
NBCIE families. A total of six ABCA12
mutations were identified, and four of
them—p.Trp1235Ser in the extracellu-
lar domain between the fifth and
the sixth transmembrane domains,
p.Pro1798Leu in the extracellular do-
main close to the seventh transmem-
brane domain, p.Thr1980Lys in the
Abbreviations: LI, lamellar ichthyosis; NBCIE, non-bullous congenital ichthyosiform erythroderma; SNP,
single-nucleotide polymorphism; TGase1, transglutaminase-1
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